Clinical Trials List
2026-05-01 - 2034-12-31
Phase III
Not yet recruiting2
Recruiting4
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Wen-Chien Chou Division of General Internal Medicine
- MING YAO Division of General Internal Medicine
- - - Division of General Internal Medicine
- Tai-Chung Huang Division of General Internal Medicine
- 李婉瑄 Division of General Internal Medicine
- 李思慧 Division of Family Medicine
- - - Division of General Internal Medicine
- YAO CHI-YUAN Division of Others -
- 楊鎰聰 Division of General Internal Medicine
- 田豐銘 Division of General Internal Medicine
- Huai-Hsuan Huang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Ta-Chih Liu Division of Hematology & Oncology
- 陳彥谷 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 張力常 無
- 傅蓓安 無
- Sin-Syue Li 無
- Ya-Ping Chen 無
- Ya-Ting Hsu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳玟均 無
- 陳志丞 無
- Sheng-Hsuan Chien 無
- 蔡淳光 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin 無
- Tzu-Ting Chen 無
- Ching Yun Hsieh 無
- 王幸婷 無
- Chi-Ching Chen 無
- 鄭富銘 無
- Ming-Yu Lien 無
- Ching-Chan Lin 無
- 陳珈妤 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 許瑞峰 無
- Shih-Feng Cho 無
- 謝子禹 無
- Jeng-Shiun Du 無
- 王閔宏 無
- Tsung-Jang Yeh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
210-300 participants
